Combined therapy of pentastarch, dexamethasone, and dibutyryl-cAMP or β2-agonist attenuates ischaemia/reperfusion injury of rat lung

Injury

Volumn 39, Issue 9, 2008, Pages 1062-1070

  Lu, Hsiu Ling ^a   Chiang, Chi Huei ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

2 Adrenergic agonist; Dexamethasone; Dibutyryl cAMP; Ischaemia reperfusion lung injury; Pentastarch

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; DEXAMETHASONE; HETASTARCH; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; LUNG CIRCULATION; LUNG INJURY; LUNG WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BUCLADESINE; CYTOKINES; DEXAMETHASONE; DRUG THERAPY, COMBINATION; HETASTARCH; LUNG INJURY; MALE; PLASMA SUBSTITUTES; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; REPERFUSION INJURY; RNA, MESSENGER; VASCULAR RESISTANCE;

EID: 48649107275     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2007.10.022     Document Type: Article

References (42)

1. Axon R.N., Baird M.S., Lang J.D., et al. PentaLyte decreases lung injury after aortic occlusion-reperfusion. Am J Respir Crit Care Med 157 (1998) 1982-1990
2. Bernard G.R., Luce J.M., Sprung C.L., et al. High dose corticosteroid in patient with the adult respiratory distress syndrome. N Engl J Med 317 (1987) 1565-1570
3. Beutler B., and Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 316 (1987) 379-385
4. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic dose of hydrocortisone. Crit Care Med 26 (1998) 645-650
5. Chang D.M., Hsu K., Ding Y.A., and Chiang C.H. Interleukin-1 in ischemia-reperfusion acute lung injury. Am J Respir Crit Care Med 156 (1997) 1230-1234
6. Chiang C.H., Hsu K., Yan H.C., et al. PGE1, dexamethasone, U-74389, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury. J Appl Physiol 83 (1997) 583-590
7. Chiang C.H., Hsu K., Yu C.P., et al. Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion lung injury. Am J Respir Crit Care Med 160 (1999) 1319-1323
8. Chiang C.H., Hsu K., Yu C.P., et al. Protective agents used as additives in University of Wisconsin solution to promote protection against ischemia-reperfusion injury in rat lung. Clin Sci 95 (1998) 369-376
9. Chiang C.H., Wu C.P., Perng W.C., et al. Use of anti-(tumor necrosis factor-α) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischemia/reperfusion injury. Clin Sci 99 (2000) 215-222
10. Chiang C.H., Wu C.P., Perng W.C., et al. Dexamethasone and pentastarch produce additive attenuation of ischemia/reperfusion lung injury. Clin Sci 99 (2000) 413-419
11. Chiang C.H., Yu C.P., Wu C.P., et al. Cytokine up-regulation in ischaemic/reperfused lungs perfused with University of Wisconsin solution and normal saline. Clin Sci 101 (2000) 285-294
12. Collis R.E., Collins P.W., Gutteridge C.N., et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 20 (1994) 37-41
13. Crandall E.D., Heming T.A., Palombo R.L., and Goodman B.E. Effects of terbutaline on sodium transport in isolated perfused rat lung. J Appl Physiol 60 (1986) 289-294
14. Drake R., Gaar K.A., and Taylor A.E. Estimation of the filtration coefficient of pulmonary exchange vessels. Am J Physiol 234 (1998) H266-H274
15. Ferrara J.J., Dyess D.L., Collins J.N., et al. Effect of pentafraction administration on microvascular permeability alterations induced by graded thermal injury. Surgery 115 (1994) 182-189
16. Goodman B.E., Kim K.J., and Crandall E.D. Evidence for active sodium transport across alveolar epithelium of isolated rat lung. J Appl Physiol 62 (1987) 2460-2466
17. Hall T.S., Borkon A.M., Gurtner G.C., et al. Improved static lung preservation with corticosteroids and hypothermia. J Heart Transplant1 7 (1998) 348-352
18. Hammerschmidt D.E., White J.G., Craddock P.R., and Jacob H.D. Corticosteroid inhibit complement-induced granulocyte aggregation: a possible mechanism for their efficacy in shock states. J Clin Invest 63 (1979) 798-803
19. Haynes, Seibert A., Bass J.B., and Taylor A.E. U74500A inhibition of oxidant-mediated lung injury. Am J Physiol 259 (1990) H144-H148
20. Hooper T.L., Jones M.T., Thomson D.S., et al. Modulation of ischemic lung injury by corticosteroids. Transplantation 50 (1990) 530-532
21. Lasnier J.M., Wangensteen O.D., Schmitz L.S., et al. Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol 81 (1996) 1723-1729
22. Lomas D.A., Ip M., Chamba A., and Stockley R.A. The effect of in vitro and in vivo dexamethasone on human neutrophil function. Agents Actions 33 (1991) 279-282
23. Luce J.M., Montgomery A.B., Marks J.D., et al. Ineffectiveness of high-dose methyprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 138 (1988) 62-68
24. Matthay M.A. Alveolar fluid clearance in patients with ARDS: does it make a difference?. Chest 122 (2002) 340S-343S
25. Matthay M.A., and Wiener-Kronish J.P. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142 (1990) 1250-12572002
26. Mazzoni M.C., Borgstrom P., Intaglietta M., and Arfors K.E. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 31 (1990) 407-418
27. Meduri G.U., Chinn A.J., Leeper K.V., et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: pattern of response and predictors of outcome. Chest 105 (1994) 1516-1527
28. Moriski H., Bloos F., Keys J., et al. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 77 (1994) 1507-1518
29. Saldias F., Lecuona E., Friedman E., et al. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol 274 (1998) L694-L701
30. Saldias F.J., Lecuona E., Comellas A.P., et al. Beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. Am J Respir Crit Care Med 162 (2000) 282-287
31. Saumon G., Basset G., Bouchonnet F., and Crone C. cAMP and β-adrenergic stimulation of rat alveolar epithelium: effects on fluid absorption and paracellular permeability. Pluegers Arch 410 (1987) 464-470
32. Schell R.M., Cole D.J., Schultz R.L., and Osborne T.N. Temporary cerebral ischemia. Effects of pentastarch or albumin on reperfusion injury. Anesthesiology 77 (1992) 86-92
33. Seibert A.F., Thompson W.J., Taylor A., et al. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP. J Appl Physiol 72 (1992) 369-395
34. Shasby D.M., Shasby S.S., Sullivan J.M., and Peach M.J. Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res 51 (1982) 657-661
35. Sprung C.L., Caralis P.V., Marcial E.H., et al. The effect of high dose corticosteroid in patients with septic shock: a prospective, controlled study. N Engl J Med 311 (1984) 1137-1143
36. +-ATPase activity by β-adrenergic agonist in alveolar type II cells. Am J Physiol 268 (1995) L983-L990
37. Vincent J.L. Plugging the leaks? New insights into synthetic colloids. Crit Care Med 19 (1991) 316-318
38. Webb A.R., Tighe D., Moss R.F., et al. Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in porcine model of fecal peritonitis. Crit Care Med 19 (1991) 409-416
39. Wisselink W., Patetsios P., Panetta T.F., et al. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. J Vasc Surg 27 (1998) 109-116
40. Yue G., Shoemaker R., and Matalon S. Regulation of low-amiloride-affinity sodium channels in alveolar type II cells. Am J Physiol 267 (1994) L94-L100
41. Zikria B.A., Subbarao C., Oz M.C., et al. Hyroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 125 (1990) 930-934
42. Zikria B.A., Subbarao C., Oz M.C., et al. Macromocules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 17 (1989) 1306-1309